Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-03-31
1996-11-05
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514335, 514444, 514471, 514472, 514473, 514461, 514532, 514538, 514539, 514530, 514455, 514437, A61K 3144, A61K 3138, A61K 3134, A61K 31235, A61K 3124, A61K 31215, A61K 3135
Patent
active
055718256
ABSTRACT:
The present invention provides a method of selectively inhibiting prostaglandin G/H synthase-2 that comprises administering to a patient in need of such inhibition an inhibiting amount of a compound having the Formula I, II or III ##STR1## wherein the R groups and heterocycles are defined in the disclosure.
REFERENCES:
patent: 3558640 (1971-01-01), Shen et al.
patent: 4066686 (1978-01-01), Lafon
patent: 4205087 (1980-05-01), Waring
patent: 4489095 (1984-12-01), Lafon
patent: 4964893 (1990-10-01), Brannigan et al.
patent: 5366982 (1994-11-01), Dereu et al.
Remingtons Pharmaceutical Sciences, 16th Ed., 1980, p. 431.
Boschelli Diane H.
Connor David T.
Dyer Richard D.
Khatana Sonya S.
Kramer James B.
Cintins Marianne M.
Crissey Todd M.
Jarvis William R. A.
Warner-Lambert & Company
LandOfFree
Method of selectively inhibiting prostaglandin G/H synthase-2 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of selectively inhibiting prostaglandin G/H synthase-2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of selectively inhibiting prostaglandin G/H synthase-2 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2015413